%0 Generic
%T ARV-471, an estrogen receptor (ER) PROTACdegrader, combined with palbociclib in advanced ER+/human epidermal growth factor receptor 2–negative (HER2-) breast cancer: Phase 1b cohort (part C) of a phase 1/2 study.
%A Hamilton, Erika P.
%A Schott, Anne F.
%A Nanda, Rita
%A Lu, Haolan
%A Keung, Chi Fung
%A Gedrich, Richard
%A Parameswaran, Janaki
%A Han, Hyo S.
%A Hurvitz, Sara A.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%D 2022
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation